NM_002875.5:c.55A>G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_002875.5(RAD51):c.55A>G(p.Ser19Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000297 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002875.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAD51 | ENST00000267868.8 | c.55A>G | p.Ser19Gly | missense_variant | Exon 2 of 10 | 1 | NM_002875.5 | ENSP00000267868.3 | ||
RAD51 | ENST00000532743.6 | c.55A>G | p.Ser19Gly | missense_variant | Exon 2 of 10 | 2 | ENSP00000433924.2 | |||
RAD51 | ENST00000557850.5 | c.55A>G | p.Ser19Gly | missense_variant | Exon 2 of 8 | 2 | ENSP00000454176.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251470Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135904
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461864Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 727232
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74370
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.S19G variant (also known as c.55A>G), located in coding exon 1 of the RAD51 gene, results from an A to G substitution at nucleotide position 55. The serine at codon 19 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at